Tolerance and safety of inhaled hypertonic saline solutions in patients with chronic bronquial infection.
D. Velasco Álvarez (Madrid, Spain), D. Durán Barata (Madrid, Spain), R. Nieto Royo (Madrid, Spain), R. Morillo Guerrero (Madrid, Spain), A. Solier López (Madrid, Spain), C. Almonacid Sánchez (Castilla-La Mancha, Spain), E. Barbero Herranz (Madrid, Spain), B. Pintado Cort (Madrid, Spain), A. Pérez Figuera (Madrid, Spain), L. Máiz Carro (Madrid, Spain)
Source: International Congress 2022 – Pleural and other respiratory infections
Session: Pleural and other respiratory infections
Session type: Thematic Poster
Number: 1107
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Velasco Álvarez (Madrid, Spain), D. Durán Barata (Madrid, Spain), R. Nieto Royo (Madrid, Spain), R. Morillo Guerrero (Madrid, Spain), A. Solier López (Madrid, Spain), C. Almonacid Sánchez (Castilla-La Mancha, Spain), E. Barbero Herranz (Madrid, Spain), B. Pintado Cort (Madrid, Spain), A. Pérez Figuera (Madrid, Spain), L. Máiz Carro (Madrid, Spain). Tolerance and safety of inhaled hypertonic saline solutions in patients with chronic bronquial infection.. 1107
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|